Related Experiment Video
Updated: Jun 25, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Serum LRG1 as a non-invasive biomarker for identifying complex coronary anatomy in pre-angiography risk
Zhengkai Yang1, Zirui Liu2, Ying Xu2
1Cardiology Department, Hulunbuir People's Hospital, Hulunbuir City, Inner Mongolia Autonomous Region, China.
Background:
The SYNTAX Score provides a quantitative evaluation of the complexity of coronary anatomy and informs revascularization strategies; however, its reliance on invasive angiography limits its use in early non-invasive risk assessment. Leucine-rich alpha-2 glycoprotein-1 (LRG1), a novel serum biomarker associated with inflammation and vascular injury, has an unclear relationship with the SYNTAX Score. This study aims to investigate whether LRG1 is an independent risk factor for complex coronary lesions. Furthermore, we explored if a combined model with LDL-C could improve predictive performance.
Methods:
Bioinformatics analyses were conducted on GEO datasets (GSE60993, GSE62646) to compare stable coronary artery disease (SCAD) with ST-elevation myocardial infarction (STEMI), as well as healthy individuals with acute myocardial infarction (AMI) patients. Serum levels of LRG1 were quantified using enzyme-linked immunosorbent assay (ELISA). Statistical approaches, including least absolute shrinkage and selection operator (LASSO) regression and Boruta feature selection, were employed to identify independent risk factors, which were subsequently incorporated into a logistic regression model. The diagnostic performance of the model was evaluated using receiver operating characteristic (ROC) curve analysis, calibration tests, and decision curve analysis.
Results:
GEO database analysis revealed significant overexpression of LRG1 in patients with AMI. This single-center observational study included 138 patients with confirmed coronary artery disease (CAD). Serum LRG1 levels were significantly elevated in AMI patients compared to non-AMI patients. Furthermore, individuals with SYNTAX Scores ≥ 23 demonstrated higher serum LRG1 concentrations than those with Scores < 23 [277.2 (122.8-393.6) μg/mL vs. 113.4 (65.8-248.9) μg/mL, P < 0.001]. Feature selection using the Boruta algorithm and LASSO regression identified LRG1 and low-density lipoprotein cholesterol (LDL-C) as independent predictors of elevated SYNTAX Score ≥ 23. The logistic regression model, depicted as a nomogram, exhibited moderate discriminatory ability (AUC = 0.771, 95% CI: 0.685-0.856), excellent calibration (Hosmer-Lemeshow test, P = 0.416), and demonstrated clear clinical net benefit.
Conclusions:
This study provides preliminary evidence that serum LRG1, in conjunction with LDL-C, may serve as a non-invasive adjunct for identifying CAD patients with complex coronary anatomy (SYNTAX Score ≥23).
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
